Searched for
INFERIOR DRUGS
Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...- Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...
- Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
- Dr. Reddy’s Lab launches India’s first DCGI-approved Semaglutide injection for Type 2 DiabetesDr. Reddy's Laboratories has launched Obeda, a generic semaglutide injection for Type 2 diabetes, becoming the first Indian company to rece...
- US Supreme Court preserves key element of Obamacare preventive careThe Supreme Court has upheld a key component of Obamacare, ensuring that preventive care services like cancer screenings and HIV prevention...
- DCGI initiates review of pharma manufacturing standards to ensure drug quality and safetyIndia's drug regulator, the Drug Controller General of India (DCGI), plans to review pharmaceutical manufacturing standards in order to ens...
- BE's pediatric pneumonia jab gets CDSCO expert panel approvalThe BE's pneumococcal conjugate vaccine (PCV) can be administered to infants at 6, 10 and 14 weeks of age. Streptococcus pneumoniae infecti...
- How reduction in stent prices has made domestic players competitiveThe reduction in stent prices enthused Indian manufacturers, which had been on the fringes of the business and had been desperately trying ...
- Bare-metal stents not inferior to costlier drug-eluting ones: Norwegian studyThe observation comes at a time when India has decided to clamp price controls on stents and the govt is engaged with stakeholders in a rag...
- Hilleman Laboratories begins clinical trials of rotavirus vaccineHilleman Labs received approvals to conduct phase I and II clinical trials for the two vaccines in recent weeks from Directorate General of...
- Health ministry plans to revamp regulatory rules for biosimilar drugsOfficials say the new norms will be finalised after consultations with the industry, academic institutions and stakeholders like the civil ...
- New drug combo therapy may treat malaria in children'Artemisinin-naphthoquine drug-combo should be considered for the treatment of uncomplicated malaria in settings where multiple parasite sp...
- Digvijay Singh demands Chhattisgarh Health Minister's resignation"It is not a case of bad surgeries, but use of inferior quality medicines and equipment that the government had purchased under the Centre'...
- Report on Indian drug makers: India's legal threat a 'shocking overreaction', say US researchersNot even North Korea or Russia have taken the illiberal step of suing scholars for publishing academic research and India.
- India hits back at report of selling inferior drugs in AfricaIBEF is a trust set up by the Department of Commerce with a primary aim of promoting and creating global awareness of the 'Made in India' l...
- India-made drugs for poorer nations inferior, says US think tank studyUS think tank study points out that Indian drug makers make poor quality drugs for Africa; pharma companies dub the report as non-transpare...
- Quality drugs will be imported from India: Sri LankaSri Lanka on Wednesday said quality drugs will be imported from India to meet the shortage of essential medicines in the country.
- Ranbaxy, DRL asthma pills to get 93 per cent cheaperDrug price regulator National Pharmaceutical Pricing Authority (NPPA) has started deciding the MRP for anti-asthma drug Doxofylline in a mo...
- Dr Reddy's looks for partner to enter Japanese mktDr Reddy’s Laboratories is finalising plans to enter the Japanese market, the world’s second largest pharmaceutical market.
- Dr Reddy's scouts for partner to enter Japanese marketThe Hyderabad-based company is looking for a partner to launch its products in Japan by next fiscal year. Smart ways to invest or spend!
Load More
